Skip to content

Nasdaq · CIK 0000882291

AEMD AETHLON MEDICAL INC

Insider trading from SEC Form 4. Last filing Jul 1, 2026.

In brief

AETHLON MEDICAL INC (AEMD) has 32 SEC Form 4 filings on file from 4 insiders, the latest filed on Jul 1, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company

Signals

Open-market buys and sells at AETHLON MEDICAL INC, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

Every row filed, 32 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 30, 2026Nicolas Gikakis
director
FTax withholding
Common Stock
-2,182$0.82$1,78920,663Jul 1, 2026
Jun 30, 2026Chetan Shah
director
FTax withholding
Common Stock
-2,182$0.82$1,78920,840Jul 1, 2026
Jun 30, 2026Edward G Broenniman
director
FTax withholding
Common Stock
-1,091$0.82$89522,363Jul 1, 2026
Apr 17, 2026Edward G Broenniman
director
AGrant or award
Common Stock
+21,815$2.29$50k23,454Apr 21, 2026
Apr 17, 2026Nicolas Gikakis
director
AGrant or award
Common Stock
+21,815$2.29$50k22,844Apr 21, 2026
Apr 17, 2026Chetan Shah
director
AGrant or award
Common Stock
+21,815$2.29$50k23,021Apr 21, 2026
Apr 17, 2026Angela Rossetti
director
AGrant or award
Common Stock
+21,815$2.29$50k26,207Apr 21, 2026
Mar 31, 2026Chetan Shah
director
FTax withholding
Common Stock
-178$2.19$3901,463Apr 1, 2026
Mar 31, 2026Nicolas Gikakis
director
FTax withholding
Common Stock
-178$2.19$3901,464Apr 1, 2026
Mar 31, 2026Edward G Broenniman
director
FTax withholding
Common Stock
-89$2.19$1951,915Apr 1, 2026
Dec 31, 2025Edward G Broenniman
director
FTax withholding
Common Stock
-89$2.77$2472,807Jan 2, 2026
Dec 31, 2025Nicolas Gikakis
director
FTax withholding
Common Stock
-179$2.77$4962,357Jan 2, 2026
Dec 31, 2025Chetan Shah
director
FTax withholding
Common Stock
-179$2.77$4962,356Jan 2, 2026
Sep 30, 2025Nicolas Gikakis
director
FTax withholding
Common Stock
-1,786$0.75$1,33822,683Oct 2, 2025
Sep 30, 2025Edward G Broenniman
director
FTax withholding
Common Stock
-893$0.75$66925,397Oct 2, 2025
Sep 30, 2025Chetan Shah
director
FTax withholding
Common Stock
-1,786$0.75$1,33822,672Oct 2, 2025
Jun 30, 2025Chetan Shah
director
FTax withholding
Common Stock
-1,786$1.20$2,14319,993Jul 1, 2025
Jun 30, 2025Edward G Broenniman
director
FTax withholding
Common Stock
-893$1.20$1,07221,825Jul 1, 2025
Jun 30, 2025Nicolas Gikakis
director
FTax withholding
Common Stock
-1,786$1.20$2,14320,004Jul 1, 2025
Apr 23, 2025Chetan Shah
director
AGrant or award
Common Stock
-142,857$0.36$51k174,233Apr 25, 2025
Apr 23, 2025Edward G Broenniman
director
AGrant or award
Common Stock
+142,857$0.35$50k181,741Apr 25, 2025
Apr 23, 2025Angela Rossetti
director
AGrant or award
Common Stock
+142,857$0.35$50k343,400Apr 25, 2025
Apr 23, 2025Nicolas Gikakis
director
AGrant or award
Common Stock
+142,857$0.35$50k174,320Apr 25, 2025
Mar 31, 2025Nicolas Gikakis
director
FTax withholding
Common Stock
-3,289$0.36$1,17731,463Apr 1, 2025
Mar 31, 2025Chetan Shah
director
FTax withholding
Common Stock
-3,289$0.36$1,17731,376Apr 1, 2025
Mar 31, 2025Edward G Broenniman
director
FTax withholding
Common Stock
-1,645$0.36$58938,884Apr 1, 2025
Dec 31, 2024Nicolas Gikakis
director
FTax withholding
Common Stock
-3,289$0.86$2,82934,752Jan 3, 2025
Dec 31, 2024Chetan Shah
director
FTax withholding
Common Stock
-3,289$0.86$2,82934,665Jan 3, 2025
Dec 31, 2024Edward G Broenniman
director
FTax withholding
Common Stock
-1,645$0.86$1,41540,529Jan 3, 2025
Dec 29, 2023Chetan Shah
director
FTax withholding
Common Stock
-1,163$2.19$2,54712,801Jan 2, 2024
Dec 29, 2023Edward G Broenniman
director
FTax withholding
Common Stock
-1,163$2.19$2,54713,733Jan 2, 2024
Dec 29, 2023Nicolas Gikakis
director
FTax withholding
Common Stock
-1,954$2.19$4,27915,634Jan 2, 2024

Insiders

Everyone who has filed a Form 4 here.

Questions about AEMD

Answered from the filings on this page, as of the latest one.

Are insiders buying AEMD?

No. In the last 90 days no insider at AETHLON MEDICAL INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade AEMD on the open market?

No open-market trade has been scored at AETHLON MEDICAL INC. The latest Form 4 on file was filed on Jul 1, 2026 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at AETHLON MEDICAL INC?

4 people have filed a Form 4 at AETHLON MEDICAL INC, among them Edward G Broenniman (director), Nicolas Gikakis (director), Angela Rossetti (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

AEMD insider trading: AETHLON MEDICAL INC | InsiderTell